What is NexGard Chewables?
NexGard Chewables are a type of medication used to help prevent and treat fleas and ticks in dogs. They come in beef-flavored soft chewable tablets that are easy to administer and are available in different sizes based on your dog's weight. The medication works by killing fleas and ticks quickly and effectively while also preventing future infestations.
NexGard Chewables are an effective treatment for fleas and ticks and are recommended by veterinarians. The chewables are easy to administer and dogs love the beef-flavored taste. The medication starts working within hours of administration and can continue to provide protection for up to 30 days.
It is important to follow the dosing instructions provided by your veterinarian or on the packaging of the medication. Additionally, you should always consult with your veterinarian prior to starting any new medication for your pet to ensure it is the right fit for their unique needs.
NexGard Chewables are a popular and reliable option for pet owners looking to protect their dogs from fleas and ticks. If you have any questions about this medication or are considering it for your pet, you should speak with your veterinarian to learn more.
Frequently Asked Questions about nexgard chewables
NexGard is a beef-flavored monthly soft chewable that kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of Black-legged (deer) tick (Ixodes scapularis), American Dog tick (Dermacentor variabilis), Lone Star tick (Amblyomma ...
NexGard is a medicine used to treat infestations with fleas and ticks, as well as demodectic and sarcoptic mange (skin infestations caused by two different types of mites) in dogs. It may be used as part of the management of flea allergy dermatitis (an allergic reaction to flea bites).
Nexgard Spectra contains the active substances afoxolaner and milbemycin oxime.
Advantages of Nexgard chew
- Nexgard is a fast acting formula.
- The single chew kills both fleas and ticks.
- It is safe and effective for full 30 days.
- More powerful than other oral flea control products.
- It is a soft, beef-flavoured chew.
- Dogs readily consume it.
- NexGard kills adult fleas before they lay eggs.
NexGard® and NexGard SPECTRA® kill fleas by over-stimulating their nervous system, which results in uncontrolled activity of their nervous system and death. This occurs within 6-8 hours of product administration.
NexGard works quickly, entering the bloodstream within 30 minutes of ingestion. It starts killing fleas within 4 hours and ticks within 12 hours. One study found that afoxolaner kills existing fleas within 2 to 6 hours and maintains an average mortality rate of between 97.6% to 100% for 3 weeks after treatment.
Boehringer Ingelheim Animal Health in recent years has expanded vaccine and drug factories in Georgia and Missouri. The 48-year-old Puerto Rico plant now manufactures the heartworm preventive Heartgard Plus (ivermectin/pyrantel) and packages Brazilian-made NexGard chewables for shipment to the United States and Canada.
Hearwtorks, intestinal worms, fleas and ticks:
Nexgard Spectra is a multicoverage product that protects against all common parasites (it is not the same as Nexgard Flea and Tick!). Nexgard Spectra does not protect against tapeworm.
NexGard or NexGard SPECTRA are both ideal choices for dogs with flea allergy dermatitis (FAD) due to their rapid speed of kill and month-long protection against fleas. For dogs with a flea allergy, monthly treatment with NexGard or NexGard SPECTRA should continue throughout the year without interruption.
NexGard should be used on dogs only. Can I administer it more than once a month? Don't re-administer NexGard before the month is through. It keeps working for a full 30 days.
NexGard should be used on dogs only. Can I administer it more than once a month? Don't re-administer NexGard before the month is through. It keeps working for a full 30 days.
Boehringer Ingelheim
NexGard Indicated for External Parasites in Canines | Boehringer Ingelheim.
